Literature DB >> 28443195

Synthesis, quality control and determination of metallic impurities in 18F-fludeoxyglucose production process.

Krzysztof Kilian1, Bartłomiej Chabecki2, Justyna Kiec2, Agnieszka Kunka2, Barbara Panas2, Maciej Wójcik2, Anna Pękal1.   

Abstract

AIM: The aim of this study was to synthesize 18FDG in some consecutive runs and check the quality of manufactured radiopharmaceuticals and to determine the distribution of metallic impurities in the synthesis process.
BACKGROUND: For radiopharmaceuticals the general requirements are listed in European Pharmacopeia and these parameters have to be checked before application for human use.
MATERIALS AND METHODS: Standard methods for the determination of basic characteristics of radiopharmaceuticals were used. Additionally, high resolution γ spectrometry was used for the assessment of nuclidic purity and inductively coupled plasma with mass spectrometry to evaluate metallic content.
RESULTS: Results showed sources and distribution of metallic and radiometallic impurities in the production process. Main part is trapped in the initial separation column of the synthesis unit and is not distributed to the final product in significant amounts.
CONCLUSIONS: Produced 18FDG filled requirements of Ph.Eur. and the content of radionuclidic and metallic impurities was in the acceptable range.

Entities:  

Keywords:  18FDG; Gamma-spectrometry; Radionuclidic impurities; Radiopharmaceuticals

Year:  2014        PMID: 28443195      PMCID: PMC5394716          DOI: 10.1016/j.rpor.2014.03.001

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  20 in total

1.  A simple method for the quality control of [(18)F]FDG.

Authors:  J Koziorowski
Journal:  Appl Radiat Isot       Date:  2010-03-06       Impact factor: 1.513

2.  Radioactive byproducts in [18O]H2O used to produce 18F for [18F]FDG synthesis.

Authors:  Shigeki Ito; Hitoshi Sakane; Shizuhiko Deji; Takuya Saze; Kunihide Nishizawa
Journal:  Appl Radiat Isot       Date:  2005-11-15       Impact factor: 1.513

3.  Analysis of metal radioisotope impurities generated in [(18)O]H(2)O during the cyclotron production of fluorine-18.

Authors:  J M Gillies; N Najim; J Zweit
Journal:  Appl Radiat Isot       Date:  2005-11-15       Impact factor: 1.513

4.  Measurement of long lived radioactive impurities retained in the disposable cassettes on the Tracerlab MX system during the production of [18F]FDG.

Authors:  D Ferguson; P Orr; J Gillanders; G Corrigan; C Marshall
Journal:  Appl Radiat Isot       Date:  2011-05-30       Impact factor: 1.513

5.  A color spot test for the detection of Kryptofix 2.2.2 in [18F]FDG preparations.

Authors:  B H Mock; W Winkle; M T Vavrek
Journal:  Nucl Med Biol       Date:  1997-02       Impact factor: 2.408

6.  Assessing the performance and longevity of Nb, Pt, Ta, Ti, Zr, and ZrO₂-sputtered Havar foils for the high-power production of reactive [18F]F by proton irradiation of [18O]H2O.

Authors:  K Gagnon; J S Wilson; E Sant; C J Backhouse; S A McQuarrie
Journal:  Appl Radiat Isot       Date:  2011-02-25       Impact factor: 1.513

7.  Tritium in [18O]water containing [18F]fluoride for [18F]FDG synthesis.

Authors:  Shigeki Ito; Takuya Saze; Hitoshi Sakane; Satoshi Ito; Shinichi Ito; Kunihide Nishizawa
Journal:  Appl Radiat Isot       Date:  2004-12       Impact factor: 1.513

8.  Interim 18F-FDG PET in Hodgkin lymphoma: would PET-adapted clinical trials lead to a paradigm shift?

Authors:  Lale Kostakoglu; Andrea Gallamini
Journal:  J Nucl Med       Date:  2013-07       Impact factor: 10.057

9.  Radionuclide impurities in proton-irradiated [18O]H2O for the production of 18F-: activities and distribution in the [18F]FDG synthesis process.

Authors:  Louise Bowden; Luis León Vintró; Peter I Mitchell; Ruairi G O'Donnell; Anne Marie Seymour; George J Duffy
Journal:  Appl Radiat Isot       Date:  2008-11-08       Impact factor: 1.513

10.  The role of fluorodeoxyglucose positron emission tomography-computerized tomography in resolving therapeutic dilemmas in pediatric Hodgkin lymphoma.

Authors:  Rachna Seth; Kriti Puri; Prashant Singh; Panneer Selvam; Rakesh Kumar
Journal:  Indian J Nucl Med       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.